Pathstone Family Office, LLC Biomarin Pharmaceutical Inc Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
A detailed history of Pathstone Family Office, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Pathstone Family Office, LLC holds 3,275 shares of BMRN stock, worth $227,645. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,275Holding current value
$227,645% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding BMRN
# of Institutions
632Shares Held
185MCall Options Held
1.63MPut Options Held
1.2M-
Black Rock Inc. New York, NY22.7MShares$1.58 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.32 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.31 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$968 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$674 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...